Profits soar at Bell Financial Group Ltd, is it a buy?

Bell Financial Group Ltd's (ASX:BFG) 10-month profit is up 31%.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Stockbroker Bell Financial Group Ltd (ASX: BFG) released an update earlier today showing that profit before tax (PBT) was up 31% to $21.6 million for the first 10 months of 2016. The result is driven by revenue being 10% higher at $151 million, which indicates operating leverage at play.

The company's core Retail Equities division recorded 14% revenue growth to $96.6 million and generated PBT of $11.5 million. Meanwhile the higher margin Institutional Broking and Corporate Finance division registered flat revenues and PBT of $6.6 million. Results were mixed in the other three smaller divisions with revenue down 5% in Futures and FX up 25%.

The market responded well to the news with shares trading 3.6% higher earlier today, albeit on low volumes.

With a market capitalisation of $187.1 million, Bell looks to be trading on a forward price-to-earnings ratio (PER) of around 10 if you annualise its 10-month performance. It also pays an attractive 6.8% fully franked dividend.

Sounds cheap in the context of 31% profit growth, right?

Whilst this year's result sounds impressive compared to last year, investors should be aware that Bell's fortunes largely depend on the financial markets and profits can therefore fluctuate wildly. For example, in 2012 revenue fell 23.6% to $66.5 million and PBT swung from $9.3 million to a loss of $2.7 million.

Furthermore, Bell's share price is just 30% of what it was when it listed in 2007 prior to the GFC. Due to the cyclicality of the business there have been extreme peaks and troughs along the way, but the overall trend is clearly in the downward direction. Like all cyclical stocks, the best time to buy them is usually when sentiment is at its worst, but personally I tend to try to avoid them altogether.

Motley Fool contributor Matt Brazier has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »